Loading clinical trials...
Loading clinical trials...
Clinical and Microbiological Parameters in Patients With Early Lyme Neuroborreliosis
The purpose of this study is to determine clinical course and the sequelae of early Lyme neuroborreliosis after treatment with ceftriaxone.
Age
15 - No limit years
Sex
ALL
Healthy Volunteers
Yes
UMC Ljubljana, Department of Infectious Diseases
Ljubljana, Slovenia
Start Date
January 1, 2009
Primary Completion Date
December 31, 2018
Completion Date
December 1, 2020
Last Updated
October 16, 2018
50
ESTIMATED participants
ceftriaxone
DRUG
Lead Sponsor
University Medical Centre Ljubljana
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions